BFM
CALC icon

Boothbay Fund Management’s CalciMedica CALC Stock Holding History

Boothbay Fund Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-76,855
Closed -$506K – 2093
2025
Q4 		$506K Buy
+76,855
New +$300K 0.01% 1138

Other funds holding CALC

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Boothbay Fund Management's CALC Position: Q1 2026 in Review

Boothbay Fund Management sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 76,855 shares — an estimated $506K sold.

Boothbay Fund Management first reported a position in CALC in Q4 2025 and held it in 1 quarter. The position peaked at $506K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Boothbay Fund Management reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 76,855 CalciMedica shares in Q1 2026, an estimated $506K.
  • Boothbay Fund Management first reported a position in CalciMedica in Q4 2025 and held it in 1 quarter.
  • Boothbay Fund Management's CalciMedica position peaked at $506K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.